Timing of Coronary Angiography in NSTE-ACS With ADHF
Key facts
- Who runs it
- Chonnam National University Hospital
- Where
- South Korea1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Terminated
- People taking part
- 316 people enrolled
- Started
- 1 Apr 2021
- Ended
- 1 Mar 2024
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Immediate coronary angiography within 2 hours after randomization
- Delayed coronary angiography after stabilization of heart failure
- Record updated
- 1 March 2024
- Why it stopped
- Slow enrollment
Who can take part
- Age
- 19 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Age more than 18 years old
- NSTE-ACS*
- Pulmonary congestion or edema on chest X-ray; The definition of NSTE-ACS; Among patients with typical angina, dyspnea or chest discomfort without definite non-cardiac causes, at least 1 presentations of angina that suggest a NSTE-ACS:
- Rest angina, which is usually more than 20 minutes in duration
- New onset angina that markedly limits physical activity
- Increasing angina that is more frequent, longer in duration, or occurs with less exertion than previous angina; A 12-lead electrocardiogram should have no ST-segment elevation. Cardiac troponin may elevate (non-ST-segment elevation myocardial infarction) or not elevate (unstable angina pectoris)
Who cannot take part
- Cardiogenic shock* 2) Heart failure of other causes rather than NSTE-ACS 3) Terminal malignancy 4) Life expentancy < 1 year 5) Pregnancy or lactation
- Pulmonary congestion on chest X-ray or increased left ventricular filling pressure by cardiac catheterization
- The definition of cardiogenic shock All these criteria should be met
- Systolic blood pressure < 90 mmHg for 30 minutes, or needing inotropics or vasopressor to maintain systolic blood pressure > or = 90 mmHg
- At least one criteria of organ dysfunction - mental obtundation, clammy ski, ogliuria, renal dysfunction, increased level of blood lactate
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The investigators hypothesized that immediate coronary angiography (CAG) within 2 hours after admission can reduce mortality compared to delayed CAG after stabilization of acute decompensated heart failure (ADHF) in patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS) complicated by ADHF. Patients with NSTE-ACS complicated by ADHF will be randomized to immediate CAG (coronary angiography < 2 hours after randomization) or delayed CAG after stablization group by 1:1 fashion. This study is a prospective, non-blinded, randomized trial.
The 2 groups in the trial
- Immediate coronary angiography groupTreatment being tested
Immediate coronary angiography group will routinely receive coronary angiography within 2 hours after randomization.
Treatment: Immediate coronary angiography within 2 hours after randomization
- Delayed coronary angiography groupExisting treatment, for comparison
Delayed coronary angiography group will receive coronary angiography during hospitalization after stabilization of symptoms and signs of heart failure.
Treatment: Delayed coronary angiography after stabilization of heart failure
Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Immediate Versus Delayed Coronary Angiography in Patients With Non-ST-Segment Acute Coronary Syndrome With Acute Decompensated Heart Failure
- Publications
- Immediate versus delayed coronary angiography in patients with non-ST segment elevation acute coronary syndrome complicated with acute decompensated heart failure: The EARLY-HF randomized clinical trial.Cardiovascular revascularization medicine : including molecular interventions, 2026
- Record updated
- 1 March 2024